Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d] pyrimidine derivatives as mTOR inhibitors
Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d] pyrimidine derivatives as mTOR inhibitors
复制标题
新型4-吗啉代-7,8-二氢-5H-噻喃并[4,3-d]嘧啶衍生物作为mTOR抑制剂的设计、合成、抗癌活性和对接研究
DOI:
10.1016/j.bmc.2014.11.003
复制
发表时间:
2014-12-15
影响因子:
3.5
通讯作者:
Zheng, Pengwu
中科院分区:
文献类型:
--
作者:
Zhu, Wufu;Sun, Chengyu;Zheng, Pengwu
A series of 7,8-dihydro-5H-thiopyrano[4,3-d] pyrimidine derivatives (7a-q, 10a-q) were designed, synthesized and their chemical structures were confirmed by H-1 NMR, C-13 NMR, MS and HRMS spectrum. All the compounds were evaluated for the inhibitory activity against mTOR kinase at 10 mu M level. Five selected compounds (7b, 7e, 7h, 10b and 10e) were further evaluated for the inhibitory activity against PI3K alpha at 10 mu M level, and the IC50 values against mTOR kinase and two cancer cell lines. Twelve of the target compounds exhibited moderate antitumor activities. The most promising compound 7e showed strong antitumor activities against mTOR kinase, H460 and PC-3 cell lines with IC50 values of 0.80 +/- 0.15 mu M, 7.43 +/- 1.45 mu M and 11.90 +/- 0.94 mu M, which were 1.28 to 1.71-fold more active than BMCL-200908069-1 (1.37 +/- 0.07 mu M, 9.52 +/- 0.29 mu M, 16.27 +/- 0.54 mu M), respectively. Structure-activity relationships (SARs) and docking studies indicated that the thiopyrano[4,3-d] pyrimidine scaffolds exerted little effect on antitumor activities of target compounds. Substitutions of aryl group at C-4 position had a significant impact on the antitumor activities, and 4-OH substitution produced the best potency. (C) 2014 Elsevier Ltd. All rights reserved.